Pharmacogenomic testing for clopidogrel dosage helps personalise antiplatelet therapy. Clopidogrel is an antiplatelet medication used to reduce the risk of heart attacks and strokes in patients with cardiovascular disease. Some individuals have genetic variations in the CYP2C19 gene that affect how their bodies activate the drug. Pharmacogenomic testing identifies these variants and helps healthcare providers prescribe the most appropriate medication or alternative treatment to improve cardiovascular outcomes.
Home / Tests Services / Pharmacogenomics
Pharmacogenomics · Sanger Sequencing
Clopidogrel Mutation Testing
CYP2C19 status to guide antiplatelet therapy.
Drop a photo for this test
or browse files
Overview
This test is offered for informational and preventive-health purposes. Results should be interpreted by a qualified healthcare professional alongside your clinical history, and do not by themselves constitute a medical diagnosis.
TEST DETAILS
Clopidogrel Mutation Testing
| Method | Sanger Sequencing |
|---|---|
| Gene Analysed | CYP2C19 |
| Sample Type | Blood |
| Container | EDTA Tube |
| Sample Volume | 3–5 mL |
| Turnaround Time | 7 Days |
Expert result consultation included
Related tests.
View all 13 tests →WARF
Pharmacogenomics
CYP2C9 and VKORC1 variants for safer anticoagulant dosing.
Book a test
Request a callback.
Our clinical nutrition team will confirm suitability, explain sample collection, and book your slot.
✉
EMAIL
☎
PHONE
📍
VISIT
Flat No. 02, Shivam Apartment, Behind New Era English School, Govind Nagar, Nashik, MH-422009
We reply within one working day. Your details stay confidential.
Diagnostic testing is offered for informational and preventive-health purposes and does not constitute medical diagnosis or treatment. Always consult a qualified healthcare professional before making clinical decisions.